50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
QQQ   279.94 (+1.99%)
AAPL   149.84 (-1.27%)
MSFT   241.07 (+1.97%)
META   141.61 (+5.36%)
GOOGL   100.05 (+2.62%)
AMZN   118.01 (+3.15%)
TSLA   287.81 (+1.72%)
NVDA   127.36 (+2.60%)
NIO   17.33 (+0.81%)
BABA   80.99 (+4.01%)
AMD   68.36 (+1.77%)
T   15.83 (+0.64%)
MU   51.00 (+0.83%)
CGC   3.04 (+6.29%)
F   12.18 (+2.27%)
GE   64.46 (-0.02%)
DIS   99.40 (+3.70%)
AMC   7.67 (+2.95%)
PYPL   91.12 (+6.26%)
PFE   44.43 (+0.77%)
NFLX   245.20 (+9.29%)
NASDAQ:NARI

Inari Medical - NARI Stock Forecast, Price & News

$73.07
+3.82 (+5.52%)
(As of 09/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$69.86
$74.66
50-Day Range
$65.58
$84.69
52-Week Range
$50.50
$100.00
Volume
1.18 million shs
Average Volume
691,455 shs
Market Capitalization
$3.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$94.71

Inari Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
29.6% Upside
$94.71 Price Target
Short Interest
Bearish
11.55% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.13mentions of Inari Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$11.68 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.67) to ($0.10) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.21 out of 5 stars

Medical Sector

563rd out of 1,096 stocks

Surgical & Medical Instruments Industry

60th out of 108 stocks

NARI stock logo

About Inari Medical (NASDAQ:NARI) Stock

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Stock News Headlines

Inari Medical (NASDAQ:NARI) PT Raised to $94.00
What 4 Analyst Ratings Have To Say About Inari Medical
Inari Medical (NARI) Shares Cross Above 200 DMA
Inari Medical to Host First Analyst & Investor Day
Inari Medical Announces Leadership Succession Plan
See More Headlines
Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Company Calendar

Last Earnings
8/03/2022
Today
9/28/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$94.71
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$87.00
Forecasted Upside/Downside
+29.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
8 Analysts

Profitability

Net Income
$9.84 million
Pretax Margin
-3.91%

Debt

Sales & Book Value

Annual Sales
$276.98 million
Cash Flow
$0.30 per share
Book Value
$4.76 per share

Miscellaneous

Free Float
47,037,000
Market Cap
$3.90 billion
Optionable
Not Optionable
Beta
1.49

Key Executives

  • Mr. William H. HoffmanMr. William H. Hoffman (Age 55)
    CEO, Pres & Director
    Comp: $1.35M
  • Mr. Mitchell C. HillMr. Mitchell C. Hill (Age 63)
    Chief Financial Officer
    Comp: $687.42k
  • Mr. Andrew J. HykesMr. Andrew J. Hykes (Age 49)
    Chief Operating Officer
    Comp: $750.84k
  • Dr. Thomas M. Tu M.D. (Age 49)
    Chief Medical Officer
    Comp: $752.29k
  • Ms. Janet Byk
    VP of Fin. & Accounting
  • Ms. Angela Ahmad
    Gen. Counsel & Sec.
  • Mr. Eric Khairy
    VP Marketing
  • Mr. John R. Borrell (Age 55)
    VP of Sales













NARI Stock - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price forecast for 2022?

8 Wall Street research analysts have issued twelve-month price objectives for Inari Medical's stock. Their NARI share price forecasts range from $87.00 to $100.00. On average, they anticipate the company's stock price to reach $94.71 in the next twelve months. This suggests a possible upside of 29.1% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2022?

Inari Medical's stock was trading at $91.27 at the beginning of the year. Since then, NARI stock has decreased by 19.6% and is now trading at $73.35.
View the best growth stocks for 2022 here
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our NARI earnings forecast
.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) announced its quarterly earnings data on Wednesday, August, 3rd. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.04. The business earned $92.74 million during the quarter, compared to the consensus estimate of $88.04 million. Inari Medical had a negative net margin of 4.47% and a negative trailing twelve-month return on equity of 4.60%.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $360.00 million-$370.00 million, compared to the consensus revenue estimate of $364.53 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

(NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

What is Inari Medical's stock symbol?

Inari Medical trades on the NASDAQ under the ticker symbol "NARI."

Who are Inari Medical's major shareholders?

Inari Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Macquarie Group Ltd. (5.41%), Price T Rowe Associates Inc. MD (3.68%), Franklin Resources Inc. (3.40%), Allspring Global Investments Holdings LLC (2.47%), State Street Corp (2.44%) and Brown Advisory Inc. (2.02%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Cynthia L Lucchese, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Presidio Management Group X Ll, Stanley Tang, Thomas Tu and William Hoffman.
View institutional ownership trends
.

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inari Medical's stock price today?

One share of NARI stock can currently be purchased for approximately $73.35.

How much money does Inari Medical make?

Inari Medical (NASDAQ:NARI) has a market capitalization of $3.92 billion and generates $276.98 million in revenue each year. The company earns $9.84 million in net income (profit) each year or ($0.29) on an earnings per share basis.

How many employees does Inari Medical have?

The company employs 800 workers across the globe.

How can I contact Inari Medical?

Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com.

This page (NASDAQ:NARI) was last updated on 9/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.